Diego Mauro Carneiro Pereira

Diego Mauro Carneiro Pereira

Auto-generated profile, based on publicly available information

Diego Mauro Carneiro Pereira

Disciplina de Biologia Molecular, Departamento de Bioquímica, Universidade Federal de São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2022 in Journal of Fish Biology
Verified
Journal Article
Closed access
ARAnna Carolina Resende
Anna Carolina Resende
DPDiego Mauro Carneiro Pereira
Diego Mauro Carneiro Pereira
ISIeda Cristina Schleger
Ieda Cristina Schleger
MSMaria Rosa Dmengeon Pedreiro de Souza
Maria Rosa Dmengeon Pedreiro de Souza
ANAnanda Karla Alvez Neundorf
Ananda Karla Alvez Neundorf
LDLucélia Donatti
Lucélia Donatti

1 February 2024 in Ecology and Evolution
Verified
Journal Article
Open access
ARAnna Carolina Resende
Anna Carolina Resende
DPDiego Mauro Carneiro Pereira
Diego Mauro Carneiro Pereira
Multibiomarker studies are useful to evaluate the early warning signs of environmental degradation, and their unified responses are often assessed through two common indexes, Integrated Biomarker Response (IBR) and Integrated Biological Responses version 2 (IBRv2). The R package IBRtools allows users to calculate both IBR and IBRv2 while simultaneously incorporating all the biomarkers under evaluation. The package includes functions for calculating the indexes IBR and IBRv2 and obtaining their standardized values, as well a function for radar chart creation and three example datasets. Here we describe the main algorithms involved in IBR and IBRv2 calculations, a description of the novel package and illustrate a workflow using data examples available on the package to guide the user on how to accurately acquire the values for either the IBR index or the IBRv2 index. The IBRtools package provides a user‐friendly platform for R users to obtain IBR index and IBRv2 values, making it straightforward even for large datasets.

1 January 2024 in Neotropical Ichthyology
Verified
Journal Article
Open access
PDF file
MRMarcos Otávio Ribeiro
Marcos Otávio Ribeiro
IRIsabelle Pereira Mari Ribeiro
Isabelle Pereira Mari Ribeiro
DPDiego Mauro Carneiro Pereira
Diego Mauro Carneiro Pereira
TDThais Aparecida Dulz
Thais Aparecida Dulz
CZClaudio Henrique Zawadzki
Claudio Henrique Zawadzki
ACAna Luiza de Brito Portela Castro
Ana Luiza de Brito Portela Castro
The southern region of Brazil is rich in hydric and biogeographic resources, contributing to the formation of distinct ichthyofaunistic niches and facilitating the isolation of some species. Despite the great ecological importance, there are few cytogenetic and molecular studies on the ichthyofauna of these basins. Therefore, specimens of Ancistrus abilhoai and Hemiancistrus fuliginosus were analyzed by combining cytogenetic and mitochondrial markers. Cytogenetic analysis revealed a diploid number of 2n = 48 for A. abilhoai and 2n = 56 for H. fuliginosus and Sites rDNA (by fluorescent in situ hybridization-FISH) were identified with 18S and 5S probes in synteny in pair 16 of A. abilhoai. At the same time in H. fuliginosus, these sites are located in separate pairs. Considering the Ancistrus cluster, based on COI molecular data, specimens of A. abilhoai were close to A. cirrhosushaving as sister group A. multispinis and A. brevipinnis. Regarding Hemiancistrus, H. fuliginosus specimens showed the same haplotype as the sequences of this species, available in the database, forming a distinct clade with H. aspidolepis as a sister group. The results of our work helped to better define the taxonomic status of A. abilhoai and H. fuliginosus, species endemic to southern Brazil and which have few studies within their respective genera.


24 March 2026 in Cytotechnology
Verified
Journal Article
Open access
BFBianca Zaia Franco Ferreira
Bianca Zaia Franco Ferreira
DPDiego Mauro Carneiro Pereira
Diego Mauro Carneiro Pereira
JOJessica Onyeisi
Jessica Onyeisi
RMRanyelison Silva Machado
Ranyelison Silva Machado
RTRodrigo Esaki Tamura
Rodrigo Esaki Tamura
CLCarla Lopes
Carla Lopes
Many tumor cells exhibit resistance to anoikis, facilitating their invasion and contributing to tumor metastasis. Previous studies have shown that anoikis-resistant endothelial cells overexpress syndecan-4 (SDC4), a co-receptor for growth factors that interacts with extracellular matrix (ECM) proteins. While SDC4 is well-known for its role in cellular processes such as adhesion, migration, and proliferation, its specific involvement in cell cycle dysregulation in tumor cells remains poorly understood. This study aimed to investigate the role of SDC4 in regulating the cell cycle in anoikis-resistant endothelial cells. Methods included the use of wild-type endothelial cells (EC), EJ-ras oncogene-transfected EC (EJ-ras EC), anoikis-resistant EC (Adh1-EC), and SDC4-silenced EC (miR-Syn-4-1-Adh-EC). Gene and protein expression of regulatory molecules across different phases of the cell cycle were analyzed using qPCR, western blotting, and flow cytometry. The Integrated Biomarker Response (IBR) index was employed to interpret cellular responses, and cell viability was assessed after adhesion blockade. Results showed that while cyclin D1 was highly expressed in the G1 phase, SDC4-silenced cells exhibited increased p27 expression, which impairs the activity of the cyclin E-CDK2 complex, suggesting a potential hindrance to cell cycle progression. Additionally, a reduction in cyclin B1 expression was observed. The IBR index for cyclins and CDKs was 2.19 and 3.24, respectively, following SDC4 silencing, compared to 4.72 and 4.41 in anoikis-resistant cells. Furthermore, SDC4 silencing increased the cells’ susceptibility to anoikis. These findings highlight SDC4’s ability to modulate key processes involved in cancer development, emphasizing its potential as a therapeutic target in cancer treatment.

29 August 2026 in Molecular Biology Reports
Verified
Journal Article
Open access
PDF file
DPDiego Mauro Carneiro Pereira
Diego Mauro Carneiro Pereira
AMAna Paula de Sousa Mesquita
Ana Paula de Sousa Mesquita
ACAmanda da Silva Cruz
Amanda da Silva Cruz
LDLucélia Donatti
Lucélia Donatti
HNHelena B. Nader
Helena B. Nader
CLCarla Lopes
Carla Lopes
Background: The development, differentiation, and homeostasis of adherent cells are regulated by interactions among cells, the extracellular matrix (ECM), and soluble factors. Loss of these contacts induces anoikis, a specific form of apoptosis. Tumor cells acquire resistance to anoikis, enabling them to survive without anchorage, invade the vascular system, and colonize distant organs in a process known as metastasis. Activation of the PI3K/Akt signaling pathway is the most common mechanism underlying the acquisition of anoikis resistance in cancer cells. The role of phosphoinositide 3-kinase (PI3K) in cancer is highlighted by the frequent mutation of the gene encoding the p110α catalytic subunit in the most common human cancers. In this study, we aimed to elucidate the role of PI3K (p110α catalytic subunit) in the acquisition of the anoikis-resistant phenotype and in the regulation of cellular characteristics directly related to tumorigenesis. Methods and results: To this end, we performed PIK3CA gene silencing in anoikis-resistant endothelial cells. Consequently, these cells exhibited a reversal of malignancy-associated traits, including morphological characteristics, anoikis resistance, clonogenic potential, proliferation rate, invasiveness, and adhesive capacity, resembling those of wild-type endothelial cells. Furthermore, we observed an increased rate of apoptosis, accompanied by changes in the expression of pro- and anti-apoptotic molecules, as well as increased caspase activation. Conclusions: In summary, our findings demonstrate that PIK3CA silencing reverses key features of the anoikis-resistant endothelial cell phenotype and provides new insights into the molecular mechanisms underlying anoikis resistance. Graphical Comparative diagram of the main characteristics of anoikis-resistant endothelial cells before and after PIK3CA silencing. Some elements of the graphical abstract were adapted from Servier Medical Art ( https://smart.servier.com/ , accessed 26 August 2025).